TP53 and Miyoshi myopathy: The TP53/17p13 abnormalities resulting in biallelic inactivation of the TP53 have a clear negative impact on progression-free survival and overall survival, and, thus, are regarded as driver events for MM relapse [61,82,86,328,530,538,539].